Multiple Sclerosis Clinical Trial
Official title:
Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most?
Verified date | January 2019 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Impaired standing balance, fatigue and abnormal eye movements are common problems in persons
with MS. These complaints are related to advanced disability and decreased quality of life
for persons with MS. Researchers from the University of Colorado and the Rocky Mountain
Multiple Sclerosis Center (RMMSC) at the Anschutz Medical Campus have recently completed and
published a research study that showed an exercise program consisting of balance and eye
movement training, referred to as a vestibular rehabilitation program, was very effective in
improving self-reported fatigue and standing balance in persons with MS. This initial study
was the first to have proven that this type of exercise program is able to improve both of
these potentially devastating complaints.
The investigators from this initial study have partnered with other well-established
researchers from the University of Colorado Anschutz Medical Campus and the Rocky Mountain
Multiple Sclerosis Center (RMMSC) at the Anschutz Medical Campus to advance our knowledge of
the effect of vestibular rehabilitation for persons with MS. Using the findings from the
initial study, the investigators propose to conduct a larger study specifically identifying
persons with MS who have brain lesion involvement in areas that control balance and eye
movements. Primarily, the current study will determine if those individuals who have
involvement in these areas of the brain improve more in balance and fatigue compared to those
who do not following participation in a vestibular rehabilitation program. Additionally, the
investigators will test if study participants who have abnormal eye movement control, will
improve their eye movement control following the training program. For persons with MS,
impaired eye movements can lead to a considerable decline in health status, further
illustrating the importance of the research plan to study this important factor.
The investigators believe that greater improvements in balance and fatigue are possible from
a longer treatment, and that participants who have brain lesion involvement in areas that
help control balance and eye movements will benefit greater than those who do not. This
information is important to determine who is more likely to benefit from a vestibular
rehabilitation program. Additionally, the researchers will be able to measure changes in eye
movement control, providing valuable insight into the reasons for the program's
effectiveness.
Status | Completed |
Enrollment | 88 |
Est. completion date | August 2018 |
Est. primary completion date | August 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - clinically definite MS confirmed by a neurologist - walk 100 meters with no greater than intermittent or unilateral constant assistive device support (coinciding with a Kurtzke Expanded Disability Status Scale (EDSS) range of 1.0 to 6.0: 1.0 to 4.5 fully ambulatory without assistive device; 5.0 to 5.5 impaired ambulatory status without assistive device; 6.0 impaired ambulatory status with intermittent or unilateral constant assistive) - 18 to 60 years of age - able to speak, read and understand English - provide informed consent - report at least a moderate level of fatigue (MFIS total score > 22) - at least moderate level of impaired balance (SOT composite score < 82) - minimal leg spasticity: score of <1 for the legs on the Modified Ashworth spasticity scale (score range: 0 - 4; 0 indicates no spasticity present, 4 is legs are rigid in all directions; 1 = indicates slight increased muscle tone) Exclusion Criteria: - non-ambulatory - use of unilateral or bilateral foot, ankle and/or knee orthoses. - medical history of other possible causes of fatigue (e.g. major sleep disorder, clinically diagnosed major depressive disorder, anemia, hypothyroidism, B12 deficiency, cancer) - complete or legal blindness in one or both eyes. - neurological disorder which might contribute to significant balance problems, such as cerebral vascular accident, peripheral neuropathy (including diabetes mellitus), peripheral vestibular disorders (unilateral/bilateral vestibular hypofunction: benign positional paroxysmal vertigo, Meniere's disease, acoustic neuroma) - documented MS-related exacerbation in the last three months. - medical diagnosis or condition (e.g. cardiac, pulmonary, hepatic) that is considered to be an absolute or relative contraindication to participating in exercise - participation in an exercise routine specifically designed to improve balance, fatigue and/or visual stability within 12 weeks prior to study participation |
Country | Name | City | State |
---|---|---|---|
United States | University of Colorado Anschutz Medical Campus/University of Colorado Denver | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | National Multiple Sclerosis Society |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Disability due to dizziness or disequilibrium (Dizziness Handicap Inventory) | Change from Baseline in Disability due to dizziness or disequilibrium at 6 weeks 14 weeks. | 6 weeks and 14 weeks | |
Other | Change in Walk Speed (Timed 25 Foot Walk Test) | Change from Baseline in Walk Speed at 6 weeks and at 14 weeks. | 6 weeks and 14 weeks | |
Other | Change in Health Status (SF-36) | Change from Baseline in Health Status at 6 weeks and at 14 weeks. | 6 weeks and 14 weeks | |
Other | Cognition (Perceived Deficits Questionnaire) | Change from Baseline in Cognition at 6 weeks and 14 weeks. | 6 weeks and 14 weeks | |
Primary | Balance (Dynamic Posturography/Computerized Sensory Organization Test) | Change in balance from Baseline to 6 weeks and 14 weeks | 6 weeks and 14 weeks | |
Secondary | Visual Stability (Dynamic Visual Acuity and Gaze Stabilization Test) | Change from Baseline in Visual Stability at 6 weeks 14 weeks | 6 weeks and 14 weeks | |
Secondary | Perceived fatigue (Modified Fatigue Impact Scale) | Change from Baseline in Perceived fatigue at 6 weeks 14 weeks. | 6 weeks and 14 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |